Corpus GrippeCanadaV3

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Effect of expanded US recommendations for seasonal influenza vaccination: comparison of two pediatric emergency departments in the United States and Canada.

Identifieur interne : 000534 ( Main/Exploration ); précédent : 000533; suivant : 000535

Effect of expanded US recommendations for seasonal influenza vaccination: comparison of two pediatric emergency departments in the United States and Canada.

Auteurs : Anne Gatewood Hoen [États-Unis] ; David L. Buckeridge ; Katia M L. Charland ; Kenneth D. Mandl ; Caroline Quach ; John S. Brownstein

Source :

RBID : pubmed:21930745

Descripteurs français

English descriptors

Abstract

BACKGROUND

Starting in the 2006/2007 influenza season, the US Advisory Committee on Immunization Practices expanded its recommendations for seasonal influenza vaccination to include healthy children aged 24-59 months. The parallel Canadian organization, the National Advisory Committee on Immunization, did not at that time issue a similar recommendation, thereby creating a natural experiment to evaluate the effect of the policy in the United States.

METHODS

We examined data for 2000/2001 through 2008/2009 and estimated relative changes in visits to the emergency department for influenza-like illness at two pediatric hospitals, one in Boston, Massachusetts, and the other in Montréal, Quebec, following the US policy change. Models were adjusted for virologic factors, seasonal trends and all-cause utilization of the emergency department.

RESULTS

Of 1 043 989 visits to the emergency departments of the two hospitals for any reason during the study period, 114 657 visits were related to influenza-like illness. Adjusted models estimated a 34% decline in rates of influenza-like illness among children two to four years old in the US hospital relative to the Canadian hospital (rate ratio 0.66, 95% confidence interval 0.58-0.75) following the 2006 policy change of the Advisory Committee on Immunization Practices. This was accompanied by more modest declines of 11% to 18% for the other age groups studied.

INTERPRETATION

The divergence in influenza rates among children in the US and Canadian sample populations after institution of the US policy to vaccinate children two to four years of age is evidence that the recommendation of the US Advisory Committee on Immunization Practices resulted in a reduction in influenza-related morbidity in the target group and may have indirectly affected other pediatric age groups. Provincial adoption of the 2010 recommendation of the National Advisory Committee on Immunization in Canada to vaccinate children two to four years of age might positively affect influenza morbidity in Canada.


DOI: 10.1503/cmaj.110241
PubMed: 21930745


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Effect of expanded US recommendations for seasonal influenza vaccination: comparison of two pediatric emergency departments in the United States and Canada.</title>
<author>
<name sortKey="Hoen, Anne Gatewood" sort="Hoen, Anne Gatewood" uniqKey="Hoen A" first="Anne Gatewood" last="Hoen">Anne Gatewood Hoen</name>
<affiliation wicri:level="2">
<nlm:affiliation>Computational Epidemiology Group, Children's Hospital Informatics Program, Children's Hospital Boston, Boston, MA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Computational Epidemiology Group, Children's Hospital Informatics Program, Children's Hospital Boston, Boston, MA</wicri:regionArea>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Buckeridge, David L" sort="Buckeridge, David L" uniqKey="Buckeridge D" first="David L" last="Buckeridge">David L. Buckeridge</name>
</author>
<author>
<name sortKey="Charland, Katia M L" sort="Charland, Katia M L" uniqKey="Charland K" first="Katia M L" last="Charland">Katia M L. Charland</name>
</author>
<author>
<name sortKey="Mandl, Kenneth D" sort="Mandl, Kenneth D" uniqKey="Mandl K" first="Kenneth D" last="Mandl">Kenneth D. Mandl</name>
</author>
<author>
<name sortKey="Quach, Caroline" sort="Quach, Caroline" uniqKey="Quach C" first="Caroline" last="Quach">Caroline Quach</name>
</author>
<author>
<name sortKey="Brownstein, John S" sort="Brownstein, John S" uniqKey="Brownstein J" first="John S" last="Brownstein">John S. Brownstein</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:21930745</idno>
<idno type="pmid">21930745</idno>
<idno type="doi">10.1503/cmaj.110241</idno>
<idno type="wicri:Area/Main/Corpus">000493</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000493</idno>
<idno type="wicri:Area/Main/Curation">000493</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000493</idno>
<idno type="wicri:Area/Main/Exploration">000493</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Effect of expanded US recommendations for seasonal influenza vaccination: comparison of two pediatric emergency departments in the United States and Canada.</title>
<author>
<name sortKey="Hoen, Anne Gatewood" sort="Hoen, Anne Gatewood" uniqKey="Hoen A" first="Anne Gatewood" last="Hoen">Anne Gatewood Hoen</name>
<affiliation wicri:level="2">
<nlm:affiliation>Computational Epidemiology Group, Children's Hospital Informatics Program, Children's Hospital Boston, Boston, MA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Computational Epidemiology Group, Children's Hospital Informatics Program, Children's Hospital Boston, Boston, MA</wicri:regionArea>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Buckeridge, David L" sort="Buckeridge, David L" uniqKey="Buckeridge D" first="David L" last="Buckeridge">David L. Buckeridge</name>
</author>
<author>
<name sortKey="Charland, Katia M L" sort="Charland, Katia M L" uniqKey="Charland K" first="Katia M L" last="Charland">Katia M L. Charland</name>
</author>
<author>
<name sortKey="Mandl, Kenneth D" sort="Mandl, Kenneth D" uniqKey="Mandl K" first="Kenneth D" last="Mandl">Kenneth D. Mandl</name>
</author>
<author>
<name sortKey="Quach, Caroline" sort="Quach, Caroline" uniqKey="Quach C" first="Caroline" last="Quach">Caroline Quach</name>
</author>
<author>
<name sortKey="Brownstein, John S" sort="Brownstein, John S" uniqKey="Brownstein J" first="John S" last="Brownstein">John S. Brownstein</name>
</author>
</analytic>
<series>
<title level="j">CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</title>
<idno type="eISSN">1488-2329</idno>
<imprint>
<date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent</term>
<term>Age Distribution</term>
<term>Canada</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Emergency Service, Hospital</term>
<term>Humans</term>
<term>Infant</term>
<term>Influenza Vaccines</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Pediatrics</term>
<term>Practice Guidelines as Topic</term>
<term>Retrospective Studies</term>
<term>United States</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adolescent</term>
<term>Canada</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Grippe humaine ()</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Guides de bonnes pratiques cliniques comme sujet</term>
<term>Humains</term>
<term>Nourrisson</term>
<term>Pédiatrie</term>
<term>Répartition par âge</term>
<term>Service hospitalier d'urgences</term>
<term>Vaccins antigrippaux</term>
<term>États-Unis d'Amérique</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en">
<term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en">
<term>Canada</term>
<term>United States</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Age Distribution</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Emergency Service, Hospital</term>
<term>Humans</term>
<term>Infant</term>
<term>Pediatrics</term>
<term>Practice Guidelines as Topic</term>
<term>Retrospective Studies</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Canada</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Grippe humaine</term>
<term>Guides de bonnes pratiques cliniques comme sujet</term>
<term>Humains</term>
<term>Nourrisson</term>
<term>Pédiatrie</term>
<term>Répartition par âge</term>
<term>Service hospitalier d'urgences</term>
<term>Vaccins antigrippaux</term>
<term>États-Unis d'Amérique</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Canada</term>
<term>États-Unis</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<b>BACKGROUND</b>
</p>
<p>Starting in the 2006/2007 influenza season, the US Advisory Committee on Immunization Practices expanded its recommendations for seasonal influenza vaccination to include healthy children aged 24-59 months. The parallel Canadian organization, the National Advisory Committee on Immunization, did not at that time issue a similar recommendation, thereby creating a natural experiment to evaluate the effect of the policy in the United States.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>METHODS</b>
</p>
<p>We examined data for 2000/2001 through 2008/2009 and estimated relative changes in visits to the emergency department for influenza-like illness at two pediatric hospitals, one in Boston, Massachusetts, and the other in Montréal, Quebec, following the US policy change. Models were adjusted for virologic factors, seasonal trends and all-cause utilization of the emergency department.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>RESULTS</b>
</p>
<p>Of 1 043 989 visits to the emergency departments of the two hospitals for any reason during the study period, 114 657 visits were related to influenza-like illness. Adjusted models estimated a 34% decline in rates of influenza-like illness among children two to four years old in the US hospital relative to the Canadian hospital (rate ratio 0.66, 95% confidence interval 0.58-0.75) following the 2006 policy change of the Advisory Committee on Immunization Practices. This was accompanied by more modest declines of 11% to 18% for the other age groups studied.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>INTERPRETATION</b>
</p>
<p>The divergence in influenza rates among children in the US and Canadian sample populations after institution of the US policy to vaccinate children two to four years of age is evidence that the recommendation of the US Advisory Committee on Immunization Practices resulted in a reduction in influenza-related morbidity in the target group and may have indirectly affected other pediatric age groups. Provincial adoption of the 2010 recommendation of the National Advisory Committee on Immunization in Canada to vaccinate children two to four years of age might positively affect influenza morbidity in Canada.</p>
</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">21930745</PMID>
<DateCompleted>
<Year>2011</Year>
<Month>11</Month>
<Day>08</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1488-2329</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>183</Volume>
<Issue>13</Issue>
<PubDate>
<Year>2011</Year>
<Month>Sep</Month>
<Day>20</Day>
</PubDate>
</JournalIssue>
<Title>CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</Title>
<ISOAbbreviation>CMAJ</ISOAbbreviation>
</Journal>
<ArticleTitle>Effect of expanded US recommendations for seasonal influenza vaccination: comparison of two pediatric emergency departments in the United States and Canada.</ArticleTitle>
<Pagination>
<MedlinePgn>E1025-32</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1503/cmaj.110241</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Starting in the 2006/2007 influenza season, the US Advisory Committee on Immunization Practices expanded its recommendations for seasonal influenza vaccination to include healthy children aged 24-59 months. The parallel Canadian organization, the National Advisory Committee on Immunization, did not at that time issue a similar recommendation, thereby creating a natural experiment to evaluate the effect of the policy in the United States.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We examined data for 2000/2001 through 2008/2009 and estimated relative changes in visits to the emergency department for influenza-like illness at two pediatric hospitals, one in Boston, Massachusetts, and the other in Montréal, Quebec, following the US policy change. Models were adjusted for virologic factors, seasonal trends and all-cause utilization of the emergency department.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 1 043 989 visits to the emergency departments of the two hospitals for any reason during the study period, 114 657 visits were related to influenza-like illness. Adjusted models estimated a 34% decline in rates of influenza-like illness among children two to four years old in the US hospital relative to the Canadian hospital (rate ratio 0.66, 95% confidence interval 0.58-0.75) following the 2006 policy change of the Advisory Committee on Immunization Practices. This was accompanied by more modest declines of 11% to 18% for the other age groups studied.</AbstractText>
<AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">The divergence in influenza rates among children in the US and Canadian sample populations after institution of the US policy to vaccinate children two to four years of age is evidence that the recommendation of the US Advisory Committee on Immunization Practices resulted in a reduction in influenza-related morbidity in the target group and may have indirectly affected other pediatric age groups. Provincial adoption of the 2010 recommendation of the National Advisory Committee on Immunization in Canada to vaccinate children two to four years of age might positively affect influenza morbidity in Canada.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hoen</LastName>
<ForeName>Anne Gatewood</ForeName>
<Initials>AG</Initials>
<AffiliationInfo>
<Affiliation>Computational Epidemiology Group, Children's Hospital Informatics Program, Children's Hospital Boston, Boston, MA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Buckeridge</LastName>
<ForeName>David L</ForeName>
<Initials>DL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Charland</LastName>
<ForeName>Katia M L</ForeName>
<Initials>KM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mandl</LastName>
<ForeName>Kenneth D</ForeName>
<Initials>KD</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Quach</LastName>
<ForeName>Caroline</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Brownstein</LastName>
<ForeName>John S</ForeName>
<Initials>JS</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>CAT-86857</GrantID>
<Agency>Canadian Institutes of Health Research</Agency>
<Country>Canada</Country>
</Grant>
<Grant>
<GrantID>R01 LM007677</GrantID>
<Acronym>LM</Acronym>
<Agency>NLM NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R21 AI073591-02</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 LM010812</GrantID>
<Acronym>LM</Acronym>
<Agency>NLM NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>1R21A1073591-01</GrantID>
<Agency>PHS HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R21 AI073591</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01LM007677</GrantID>
<Acronym>LM</Acronym>
<Agency>NLM NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>PAN-83152</GrantID>
<Agency>Canadian Institutes of Health Research</Agency>
<Country>Canada</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Canada</Country>
<MedlineTA>CMAJ</MedlineTA>
<NlmUniqueID>9711805</NlmUniqueID>
<ISSNLinking>0820-3946</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>CMAJ. 2011 Sep 20;183(13):1464-5</RefSource>
<PMID Version="1">21930746</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017677" MajorTopicYN="N">Age Distribution</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007252" MajorTopicYN="Y">Influenza Vaccines</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010372" MajorTopicYN="N">Pediatrics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017410" MajorTopicYN="Y">Practice Guidelines as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2011</Year>
<Month>9</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2011</Year>
<Month>9</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2011</Year>
<Month>11</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">21930745</ArticleId>
<ArticleId IdType="pii">cmaj.110241</ArticleId>
<ArticleId IdType="doi">10.1503/cmaj.110241</ArticleId>
<ArticleId IdType="pmc">PMC3176865</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2001 Mar 22;344(12):889-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11259722</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Emerg Med. 2006 Mar;47(3):265.e1</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16492494</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Prev Med. 2001 May;20(4 Suppl):17-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11331127</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Health Rep. 2002;13(3):9-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12743956</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MMWR Recomm Rep. 2003 Apr 25;52(RR-8):1-34; quiz CE1-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12755288</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2004 Mar 1;38(5):678-88</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14986252</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MMWR Recomm Rep. 2004 May 28;53(RR-6):1-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15163927</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Bull World Health Organ. 1969;41(3):537-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">5309469</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Epidemiol. 1982 May;115(5):736-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7081204</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Epidemiol Infect. 1993 Feb;110(1):145-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8432318</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 1993 Oct;168(4):881-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8376833</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MMWR CDC Surveill Summ. 1997 Aug 1;46(3):1-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9259213</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Public Health. 1997 Dec;87(12):1944-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9431281</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 1999 Oct 9;354(9186):1277-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10520648</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Epidemiol. 2005 Feb 15;161(4):303-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15692073</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2005 Feb 18;23(13):1540-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15694506</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2006 Feb 3;311(5761):615-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16456066</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatrics. 2006 Jul;118(1):e1-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16818524</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2006 Jul 6;355(1):31-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16822994</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MMWR Recomm Rep. 2006 Jul 28;55(RR-10):1-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16874296</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2006 Nov 1;194 Suppl 2:S111-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17163383</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Med Inform Assoc. 2007 Sep-Oct;14(5):581-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17600100</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MMWR Recomm Rep. 2008 Aug 8;57(RR-7):1-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18685555</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Med. 2008 Oct 28;5(10):e211</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18959473</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MMWR Recomm Rep. 2009 Jul 31;58(RR-8):1-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19644442</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2010 Mar 10;303(10):943-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20215608</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MMWR Recomm Rep. 2010 Aug 6;59(RR-8):1-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20689501</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Influenza Other Respir Viruses. 2010 Sep;4(5):295-306</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20716158</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Massachusetts</li>
</region>
</list>
<tree>
<noCountry>
<name sortKey="Brownstein, John S" sort="Brownstein, John S" uniqKey="Brownstein J" first="John S" last="Brownstein">John S. Brownstein</name>
<name sortKey="Buckeridge, David L" sort="Buckeridge, David L" uniqKey="Buckeridge D" first="David L" last="Buckeridge">David L. Buckeridge</name>
<name sortKey="Charland, Katia M L" sort="Charland, Katia M L" uniqKey="Charland K" first="Katia M L" last="Charland">Katia M L. Charland</name>
<name sortKey="Mandl, Kenneth D" sort="Mandl, Kenneth D" uniqKey="Mandl K" first="Kenneth D" last="Mandl">Kenneth D. Mandl</name>
<name sortKey="Quach, Caroline" sort="Quach, Caroline" uniqKey="Quach C" first="Caroline" last="Quach">Caroline Quach</name>
</noCountry>
<country name="États-Unis">
<region name="Massachusetts">
<name sortKey="Hoen, Anne Gatewood" sort="Hoen, Anne Gatewood" uniqKey="Hoen A" first="Anne Gatewood" last="Hoen">Anne Gatewood Hoen</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000534 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000534 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    GrippeCanadaV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:21930745
   |texte=   Effect of expanded US recommendations for seasonal influenza vaccination: comparison of two pediatric emergency departments in the United States and Canada.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:21930745" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeCanadaV3 

Wicri

This area was generated with Dilib version V0.6.35.
Data generation: Tue Jul 7 13:36:58 2020. Site generation: Sat Sep 26 07:06:42 2020